Finance

The company reported a 77% YOY increase in revenue in Q3 2024 and plans to release a generic version of Novo Nordisk's GLP-1 drug on its platform in 2025.

The acquisition includes Jack's Canadian clinical assets, the authority to operate 16 medical clinics across 13 Canadian cities and the rights to operate clinics in Walmart stores in Canada.  

Last week, the wearables company announced it opened an investigation into apparent manipulation in trading its common shares following a 1-for-15 reverse stock split.

The acquisition of data company Sparta Science will allow Oura to expand its data analytics capabilities and its B2B offerings.

The investigation follows shareholder approval of a 1-for-15 reverse stock that took effect earlier this week.

Dugan Winkie, head of commercial strategy at Cedar, discusses the revenue cycle management-focused company and how it works with strategic partners to ensure payments are satisfied using conversational AI and empathetic communication.

Maite Malet, Asabys Partners director of investments and corporate development, discusses the Barcelona-based firm’s €180 million ($200 million) raise and its plans invest in 12 to 15 health tech companies to expand from the EU to the U.S.

Malınka Walaliyadde, CEO and cofounder of AKASA, discusses the advancement and current views on artificial intelligence and tuning generative AI for use to improve the coding process in healthcare and revenue cycle management to support ROI.

The funding includes $4.5 billion for the firm's core VC funds, $1.5 billion for its Creation strategy and $2 billion for separately managed accounts.

Also, Orion Health is coming up with a combined clinical solution with Te Whatu Ora.